BioCentury
ARTICLE | Finance

What to do with all that Cash

Investors say Gilead's $5B share buyback is better than sitting on cash hoard

May 17, 2010 7:00 AM UTC

Investors polled by Ebb & Flow endorsed the new three-year, $5 billion share buyback proposed last week by Gilead Sciences Inc. (NASDAQ:GILD).

At the Bank of America Merrill Lynch Healthcare conference on Thursday, Gilead President and COO John Milligan said the company envisions three uses for its existing cash and cash flow from operations: to build its existing businesses; to augment its pipeline; and to execute the share repurchase...